Sugi Predict

Sugi Predict / Compounds / SCHEMBL24536801

SCHEMBL24536801

SCHEMBL24536801

CC1(C)OB(c2ccc(-n3c4ccccc4c4cc(-n5c6ccccc6c6ccccc65)ccc43)cc2)OC1(C)C

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LIPG Q9Y5X9 13/20 0.46
▸ LPL P06858 12/20 0.46
▸ KDM4E B2RXH2 1/20 0.42
▸ ATM Q13315 1/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.42
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ CA9 Q16790 2/20 0.38
▸ P4HB P07237 1/20 0.36
▸ CA12 O43570 1/20 0.35
▸ CA3 P07451 1/20 0.35
▸ CA4 P22748 1/20 0.35
▸ CA6 P23280 1/20 0.35
▸ CA5A P35218 1/20 0.35
▸ CA7 P43166 1/20 0.35
▸ CA14 Q9ULX7 1/20 0.35
▸ CA5B Q9Y2D0 1/20 0.35
▸ IRAK4 Q9NWZ3 1/20 0.34
▸ F11 P03951 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16985933 0.93 KDM4E (0.46) LIPGLPLKDM4EATML3MBTL1
SCHEMBL20832371 0.93 LPL (0.44) LIPGLPLKDM4EATML3MBTL1
SCHEMBL792421 0.93 LPL (0.53) LIPGLPLKDM4EATML3MBTL1
SCHEMBL29662424 0.93 LPL (0.53) LIPGLPLKDM4EATML3MBTL1
SCHEMBL29492600 0.93 LPL (0.53) LIPGLPLKDM4EATML3MBTL1
SCHEMBL14849757 0.91 LPL (0.40) LIPGLPLKDM4EATML3MBTL1
SCHEMBL12582781 0.90 LPL (0.42) LIPGLPLKDM4EATML3MBTL1
SCHEMBL16225068 0.90 LIPG (0.52) LIPGLPLKDM4EATML3MBTL1
SCHEMBL23900403 0.89 LIPG (0.48) LIPGLPLKDM4EATML3MBTL1
SCHEMBL20467860 0.89 LPL (0.44) LIPGLPLKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240190901-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-06-13 — — US disclosed
US-20220310934-A1 COMPOUND INCLUDING NITROGEN EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-09-29 — — US disclosed
US-20220199912-A1 LIGHT EMITTING DEVICE AND POLYCYCLIC COMPOUND FOR THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2022-06-23 — — US disclosed
CN-108530376-B Organic small molecule material based on 2, 6-dimethyl-4-cyanophenyl receptor unit and preparation and application thereof 华南理工大学 2021-10-22 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240190901-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES OCIAD2, OCIAD1, ODC1 LIPG 323/4885LPL 197/4885KDM4E 1913/4885
US-20220310934-A1 COMPOUND INCLUDING NITROGEN EMITTING DEVICE INCLUDING THE SAME NOS1, NOX1, NPM1 LIPG 3376/4885LPL 4199/4885KDM4E 1775/4885
US-20220199912-A1 LIGHT EMITTING DEVICE AND POLYCYCLIC COMPOUND FOR THE SAME LAGE3, ASIC1, ALG3 LIPG 2253/4885LPL 2753/4885KDM4E 1437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.